Blood test may predict liver cancer treatment success
NCT ID NCT07378709
First seen Jan 31, 2026 · Last updated May 24, 2026 · Updated 20 times
Summary
This study is looking at whether certain substances in the blood can help doctors predict how well a liver cancer treatment called TACE is working. Researchers will follow 15 adults with liver cancer who are scheduled for TACE. They will take blood samples before and after treatment and compare them with CT or MRI scans to see if the blood markers match the tumor's response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
KBC Bežanijska kosa
RECRUITINGBelgrade, Serbia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.